Clinical Trial Update: A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting results for neoadjuvant therapy using bevacizumab plus a 5-fluorouracil–based doublet in patients with previously untrea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-fluorouracil (5-FU) (5-fluorouracil)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Colorectal Cancer | Phase 4 | Status: COMPLETED | Results posted: 2016-07-28